Two independent clones in myelodysplastic syndrome following treatment of acute myeloid leukemia

International Journal of Hematology

Volumn 75, Issue 2, 2002, Pages 182-186

  Masuya, Masahiro ^a   Katayama, Naoyuki ^a   Inagaki, Koichi ^b   Miwa, Hiroshi ^c   Hoshino, Natsuki ^a   Miyashita, Hiroyuki ^a   Suzuki, Hirohito ^a   Araki, Hiroto ^a   Mitani, Hidetsugu ^a   Nishii, Kazuhiro ^a   Kageyama, Shin Ichi ^a   Minami, Nobuyuki ^d   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY   (Japan)

^b Kawagoe shi   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d MIE UNIVERSITY HOSPITAL   (Japan)

Author keywords

del(7)(q22); t(11; 12); t(1; 2); Therapy related AML; Therapy related MDS

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD; BONE MARROW; CANCER CHEMOTHERAPY; CANCER RELAPSE; CASE REPORT; CELL LINEAGE; CHROMOSOME ANALYSIS; CLONAL VARIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; MYELODYSPLASTIC SYNDROME; REMISSION; ACUTE DISEASE; CELL CLONE; CHEMICALLY INDUCED DISORDER; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 2; GENE TRANSLOCATION; GENETICS; MIDDLE AGED; MYELOID LEUKEMIA; PATHOLOGY; SECOND CANCER;

ANTINEOPLASTIC AGENT;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 2; CLONE CELLS; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; LEUKEMIA, MYELOID; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; TRANSLOCATION, GENETIC;

EID: 0036463969     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982025     Document Type: Article

References (27)

1. Gale RE. Evaluation of clonality in myeloid stem-cell disorders. Semin Hematol. 1999;36:361-372.
2. Furuya T, Morgan R, Sandberg AA. Cytogenetic biclonality in malignant hematologic disorders. Cancer Genet Cytogenet. 1992; 62:25-28.
3. Pedersen-Bjergaard J, Timshel S, Andersen MK, Andersen A-ST, Philip P. Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases. Genes Chromosomes Cancer. 1998;23:337-349.
4. Park DJ, Koeffler HP. Therapy-related myelodysplastic syndromes. Semin Hematol. 1996;33:256-273.
5. Jubashi T, Nagai K, Miyazaki Y, et al. A unique case of t(15;17) acute promyelocytic leukaemia (M3) developing into acute myeloblastic leukaemia (M1) with t(7;21) at relapse. Br J Haematol. 1993;83:665-668.
6. Todisco E, Testi AM, Avvisati G, et al. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia. Leukemia. 1995;9:1583-1585.
7. Aquino VM, Schneider NR, Sandler ES. Secondary myelodysplasia with monosomy 7 arising after treatment for acute lymphoblastic leukemia in childhood. J Pediatr Hematol Oncol. 2001;23:48-50.
8. Au WY, Lam CCK, Ma ESK, Man C, Wan T, Kwong YL. Therapy-related myelodysplastic syndrome after eradication of acute promyelocytic leukemia: cytogenetic and molecular features. Hum Pathol. 2001;32:126-129.
9. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British cooperative group. Ann Intern Med. 1985;103:626-629.
10. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51: 189-199.
11. Bennett JM, Catovsky D, Daniel MT, et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol. 1991;78:325-329.
12. Horiike S, Taniwaki M, Misawa S, Abe T. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer. 1988;62: 1129-1138.
13. Whang-Peng J, Knutsen T, Jaffe ES, et al. Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlation with cytogenetic, histologic, immunophenotyping, and molecular studies. Blood. 1995;85:203-216.
14. Mochizuki N, Shimizu S, Nagasawa T, et al. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood. 2000;96:3209-3214.
15. Hanash SM, Beretta L, Barcroft CL, et al. Mapping of the gene for interferon-inducible dsRNA-dependent protein kinase to chromosome region 2p21-22: a site of rearrangements in myeloproliferative disorders. Genes Chromosomes Cancer. 1993;8:34-37.
16. Love EM, Liu Yin JA, Harrison CJ, Narayanan MN, Bhavnani M. Acute monocytic leukaemia and t(2;6)(p21;q26) translocation. Clin Lab Haematol. 1989;11:277-280.
17. Lossos IS, Bogomolski-Yahalome V, Yehuda O, et al. A novel translocation (1;2)(p34;p21-22) in acute myelomonoblastic leukemia. Cancer Genet Cytogenet. 1998;106:78-79.
18. Wong KF, Kwong YL, So CC. De novo AML with trilineage myelodysplasia and a novel t(11;12)(p15;q13). Cancer Genet Cytogenet. 1998;100:49-51.
19. Nishiyama M, Arai Y, Tsunematsu Y, et al. 11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/ myelodysplastic syndrome. Genes Chromosomes Cancer. 1999;26:215-220.
20. Hayashi Y, Raimondi SC, Behm FG, et al. Two karyotypically independent leukemic clones with the t(8;21) and 11q23 translocation in acute myeloblastic leukemia at relapse. Blood. 1989;73: 1650-1655.
21. Pui C-H, Raskind WH, Kitchingman GR, et al. Clonal analysis of childhood acute lymphoblastic leukemia with "cytogenetically independent" cell populations. J Clin Invest. 1989;83:1971-1977.
22. Ghaddar HM, Stass SA, Pierce S, Estey EH. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogeneous leukemia: implication on the overlap between the two diseases. Leukemia. 1994;8:1649-1653.
23. Tricot G, Boogaerts MA, De Wolf-Peeters C, Van den Berghe H, Verwilghen RL. The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations. Br J Haematol. 1985;59:659-670.
24. Le Beau MM, Albain KS, Larson RA, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986;4:325-345.
25. Mitelman F, Brandt L, Nilsson PG. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood. 1978;52:1229-1237.
26. Golomb HM, Alimena G, Rowley JD, Vardiman JW, Testa JR, Sovik C. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 1982;60:404-411
27. Cuneo A, Ferrant A, Michaux JL, et al. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings. Blood. 1995;85:3688-3694.